CDKN2A and pancreatic neoplasm: The melanoma genetics consortium (Genome) studied the relationship between pancreatic cancer and familial melanoma and found that the occurrence of pancreatic carcinoma significantly predicted the likelihood of finding CDKN2A mutations, with the exception of Australia [70].